IL-13 induces alternative activation of macrophages, thereby counteracting Th1-driven inflammatory processes, and is involved, together with galectin-3, in the transition from simple steatosis to MASH [79,80]. This evidence concerns the gene IL13 and metabolic dysfunction-associated steatohepatitis.